NMR Relaxometry to Characterize the Drug Structural Phase in a Porous Construct

Date
2018-06Author
Thrane, Linn W.
Berglund, Emily A.
Wilking, James N.
Vodak, David
Seymour, Joseph D.
Metadata
Show full item recordAbstract
Nuclear magnetic resonance (NMR) frequency spectra and T2 relaxation time measurements, using a high-power radio frequency probe, are shown to characterize the presence of an amorphous drug in a porous silica construct. The results indicate the ability of non-solid-state NMR methods to characterize crystalline and amorphous solid structural phases in drugs. Two-dimensional T1–T2 magnetic relaxation time correlation experiments are shown to monitor the impact of relative humidity on the drug in a porous silica tablet.
Citation
Thrane, Linn W., Emily A. Berglund, James N. Wilking, David Vodak, and Joseph D. Seymour, “NMR Relaxometry to Characterize the Drug Structural Phase in a Porous Construct,” Molecular Pharmaceutics, June 2018; 15(7): 2614-2620. doi: 10.1021/acs.molpharmaceut.8b00144